CUTANEOUS VASCULAR PROLIFERATIONS - PART-III - MALIGNANT NEOPLASMS, OTHER CUTANEOUS NEOPLASMS WITH SIGNIFICANT VASCULAR COMPONENT, AND DISORDERS ERRONEOUSLY CONSIDERED AS VASCULAR NEOPLASMS
L. Requena et Op. Sangueza, CUTANEOUS VASCULAR PROLIFERATIONS - PART-III - MALIGNANT NEOPLASMS, OTHER CUTANEOUS NEOPLASMS WITH SIGNIFICANT VASCULAR COMPONENT, AND DISORDERS ERRONEOUSLY CONSIDERED AS VASCULAR NEOPLASMS, Journal of the American Academy of Dermatology, 38(2), 1998, pp. 143-175
In this third and last part of our review of cutaneous vascular prolif
erations we include malignant vascular neoplasms and a group of hetero
geneous cutaneous neoplasms characterized by a significant vascular co
mponent. We also review some disorders that, in our opinion, have been
erroneously considered as vascular neoplasms. We review the epidemiol
ogic, histogenetic, clinical, and histopathologic aspects of Kaposi's
sarcoma in its four distinctive variants (classic, African-endemic, im
munosuppressive drug-associated, and AIDS-associated Kaposi's sarcoma)
. There is still controversy about whether Kaposi's sarcoma represents
a reactive vascular proliferation or a true neoplastic proliferation.
In any event, most authors believe that Kaposi's sarcoma does not pro
duce metastatic disease, but rather develops in multifocal fashion. Ho
wever, Kaposi's sarcoma may cause death, especially in immunosuppresse
d patients. Epithelioid hemangioendothelioma, Dabska's tumor, and reti
form hemangioendothelioma are examples of low-grade angiosarcoma. In c
ontrast, cutaneous angiosarcomas, including the clinical variants of a
ngiosarcoma of face and scalp in elderly patients, angiosarcoma associ
ated with lymphedema, and radiation-induced angiosarcoma are highly ag
gressive neoplasms with poor prognosis and most patients die within a
short period after presentation. A group of benign and relatively freq
uent cutaneous neoplasms, including multinucleate cell angiohistiocyto
ma, angiofibroma, angioleiomyoma, angiolipoma, cutaneous angiolipoleio
myoma, and cutaneous angiomyxoma are here covered because of their sig
nificant vascular component. Finally, we review briefly a series of cu
taneous disorders that have been erroneously considered as vascular ne
oplasms. Kimura's disease is an inflammatory reactive condition of unk
nown origin, ''benign'' angioendotheliomatosis is a reactive intravasc
ular proliferation of endothelial cells that occurs in the skin as a r
esponse to a variety of stimuli, ''malignant'' angioendotheliomatosis
is an intravascular lymphoma, and acral pseudolymphomatous angiokerato
ma of children (APACHE) is better interpreted as a pseudolymphoma.